GMA-7's new prime-time series The Cure is not getting axed anytime soon.
This is according to GMA Vice President for Corporate Communications Angel Javier-Cruz.
Speaking to PEP.ph (Philippine Entertainment Portal) through a phone call earlier today, May 8, the GMA executive said that as of this writing, there has been no directive from management that the run of The Cure will be cut short.
"Walang instruction to cut it short. That's not true. As of ngayon, wala."
While Cruz did not specify the exact number of weeks or months the show will air, she said that The Cure will go on its "normal run."
It was published on PEP.ph today, through the PEP Alerts column written by PEP Troika, that the new series starring Jennylyn Mercado and Tom Rodriguez might not be able to enjoy a full-season run.
They also indicated GMA-7's "six-week policy," where its TV shows are given a minimum run of six weeks once it gets the green light for airing.
If the show won't perform well on its first week in terms of ratings, they will be given another week to gain momentum.
The Kapuso network will then decide if a show will be extended or if it will already end its run on the sixth week.
It was only last April 30 when The Cure premiered on GMA-7's Telebabad block, going head-to-head against ABS-CBN's FPJ's Ang Probinsyano.
In an interview with The Cure's director Mark Reyes during its April 17 press conference, he already said that the sci-fi themed series won't have a long run.
He said, "It’s one of the series na sabi ko, let’s not make it long. I think it should not have a long duration.
"If it does, it’s probably gonna be extended for a few more weeks, pero I don't see it.
"Unless we are given the freedom to do what we want pa and give us the support talaga, we can extend this. Pero not as long as Enca, ito, we see an end to it."
Enca is Encantadia, another prime-time series of GMA-7 directed by Reyes, which aired on the first slot from July 2016 to May 2017.
PEP.ph remains open to any statements that will issued by GMA-7 regarding this matter.